/Bill Kelly

About Bill Kelly

This author has not yet filled in any details.
So far Bill Kelly has created 907 blog entries.

New model: Pfizer licenses drugs to own startup

In a first for the Big Pharma and as part of a new model, Pfizer is taking drugs from its shelves and licensing them to, while investing in, its SpringWorks Therapeutics startup. SpringWorks starts life with a major $103 million series A with help from Bain Capital Life Sciences, Bain Capital Double Impact, Orbimed and LifeArc. Pfizer’s input consists of both equity capital and royalty- and milestone-bearing licenses to a series of experimental meds. more

By |October 16th, 2017|News|0 Comments

Elidah raises funding for urological device

A Connecticut venture fund is backing a Monroe startup that is seeking FDA approval of a device to help alleviate a urological disorder affecting millions of women. In April, Newtown residents Gloria and Eric Kolb won U.S. patent protection on Monroe-based Elidah’s Elitone device to help women with stress urinary incontinence, with the Elitone device emitting mild electric impulses to stimulate and strengthen pelvic muscles. The state-backed Connecticut Innovations venture fund has committed to investing up to $750,000 in Elidah, on the heels of the company winning funding under the America’s Seed Fund program of the National Science Foundation’s Small [...]

By |October 16th, 2017|News|0 Comments

CaroGen’s Almassian: ‘Alexion should reconsider’

"Alexion's planned headquarters move to Boston shows a lack of vision and business sense," writes Bijan Almassian of CaroGen in Hartford Business.com "Instead of moving to Boston to find talent and build a pipeline, Alexion should look to the talent and technologies being developed by Connecticut universities and start-up companies.​" more

By |October 16th, 2017|News|0 Comments

Woven Orthopedics markets bone screw grips

After four years of work developing a small device to help orthopedic screws better grip surgery patients' bones, Manchester's Woven Orthopedics of Manchester, CT has hit a major milestone. Starting in May, the company officially began distributing its woven biotextile devices, which are like sleeves or wall anchors for screws, in Australia and New Zealand for use in human patients. It marks the company's first revenue and the first time its product has been used in humans. more

By |October 16th, 2017|News|0 Comments

Paul Hermes joins Biorez board of directors

Biorez has announced the election of Paul Hermes, Entrepreneur in Residence at Medtronic, to serve as an independent director on its board of directors. Based in New Haven, Biorez is a privately held early-stage regenerative medicine company engaged in developing bioresorbable scaffold implants to reconstruct and regenerate functional tissue in vivo. Its lead product candidate is an off-the-shelf implant for ACL reconstruction that spares harvesting of patient donor-tissue, and provides a better alternative to cadaver-based allograft. more

By |October 16th, 2017|News|0 Comments

Presco to exhibit at San Jose’s Medtech

CURE member Presco, a full-service product design, engineering and software development firm in Woodbridge, will be exhibiting at the MedTech Conference in San Jose’s McEnery Convention Center September 25 through 27. The MedTech Conference, the premiere gathering of medtech officials in North America, is hosted by Advanced Medical Technology Association (AdvaMed), a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world. Presco helps their clients innovate and bring breakthrough products to market. From front-end innovation to the delivery of products that meet the highest standards of performance, its multi-disciplinary team of electronics [...]

By |October 16th, 2017|News|0 Comments

Arvina’s Houston: From big pharma to biotech

John Houston spent close to 30 years in the ranks of two big biopharma R&D organizations. There was a decade at GSK followed by 18 more years at Bristol-Myers Squibb, where he built a resume around constructing their drug discovery technology base and was credited with a key role in developing a range of major franchise drugs like Opdivo and Yervoy. Then about two years ago, instead of developing new drugs, he was charged with lending a hand at shutting down two big research sites in Seattle and Wallingford, CT, while BMS set its sights on a new R&D center [...]

By |October 16th, 2017|News|0 Comments

UConn spinout ImStem receives stem cell patent

ImStem Biotechnology, a UConn spin out developing novel therapies using stem cells, was issued a patent from the USPTO for human embryonic stem cells derived mesenchymal stem cells “hES-T-MSC” or “T-MSC” and the method of producing the stem cell. more

By |October 16th, 2017|News|0 Comments

FDA clears Medtronic spinal cord device

The FDA has cleared Medtronic's latest spinal cord stimulation system for the treatment of chronic intractable pain. Designed to surmount limitations of current devices, the Intellis platform comprises an implantable neurostimulator that records patient activity around the clock, a patient programmer, and a recharger. A physician manages the treatment on a tablet that allows the wireless programming of stimulation. more

By |October 16th, 2017|News|0 Comments

CURE welcomes new member Ideation

Ideation uses web-based computing for the management of intellectual property and to enable ecosystems for innovation. Ideation software enables companies, governments, and academic and research institutions to capture, protect, value, manage, and confidentially market and even securitize their innovation at almost no cost. more

By |October 16th, 2017|News|0 Comments